Franklin Resources
NGNE icon

Franklin Resources’s Neurogene NGNE Stock Holding History

Franklin Resources’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,050
Closed -$351K – 2988
2024
Q3 		$351K Buy
+7,050
New +$273K ﹤0.01% 2437
2018
Q2 		– Sell
-67,212
Closed -$18.9M – 1511
2018
Q1 		$18.9M Buy
67,212
+482
+0.7% +$133K 0.01% 798
2017
Q4 		$15.7M Buy
66,730
+718
+1% +$168K 0.01% 850
2017
Q3 		$18.7M Hold
66,012
– – 0.01% 811
2017
Q2 		$18.6M Hold
66,012
– – 0.01% 810
2017
Q1 		$22M Sell
66,012
-3,600
-5% -$1.26M 0.01% 761
2016
Q4 		$23M Sell
69,612
-1,975
-3% -$531K 0.01% 757
2016
Q3 		$19.1M Buy
71,587
+9,290
+15% +$1.87M 0.01% 821
2016
Q2 		$8.25M Hold
62,297
– – ﹤0.01% 1005
2016
Q1 		$11M Buy
62,297
+4,380
+8% +$851K 0.01% 961
2015
Q4 		$14.5M Buy
57,917
+2,565
+5% +$675K 0.01% 922
2015
Q3 		$15.6M Buy
55,352
+25,000
+82% +$5.76M 0.01% 913
2015
Q2 		$4.21M Buy
30,352
+905
+3% +$138K ﹤0.01% 1202
2015
Q1 		$5.05M Hold
29,447
– – ﹤0.01% 1175
2014
Q4 		$4.42M Sell
29,447
-1,128
-4% -$161K ﹤0.01% 1206
2014
Q3 		$4.07M Sell
30,575
-5,107
-14% -$779K ﹤0.01% 1215
2014
Q2 		$6.69M Buy
35,682
+5,515
+18% +$1.06M ﹤0.01% 1133
2014
Q1 		$7.68M Buy
+30,167
New +$7.75M ﹤0.01% 1084

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources's NGNE Position: Q4 2024 in Review

Franklin Resources sold out of Neurogene (NGNE) in Q4 2024, closing a stake of 7,050 shares — an estimated $351K sold.

Franklin Resources first reported a position in NGNE in Q1 2014 and held it in 18 quarters. The position peaked at $23M in Q4 2016. 88 funds tracked by Wall St. Rank hold NGNE as of Q4 2024.

  • Franklin Resources reported no remaining Neurogene position as of Q4 2024 after selling out during the quarter.
  • Franklin Resources sold 7,050 Neurogene shares in Q4 2024, an estimated $351K.
  • Franklin Resources first reported a position in Neurogene in Q1 2014 and held it in 18 quarters.
  • Franklin Resources's Neurogene position peaked at $23M in Q4 2016.
  • 88 funds tracked by Wall St. Rank held Neurogene as of Q4 2024.

Based on Franklin Resources's 13F filing for Q4 2024, filed 12 Feb 2025.